Zhaoke Ophthalmology Limited (HKG:6622)

Hong Kong · Delayed Price · Currency is HKD

3.370

+0.260 (8.36%)

At close: Mar 6, 2026

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Development, Manufacturing and Marketing of Ophthalmic Drugs	69.32M	18.75M	-	-	-
Development, Manufacturing and Marketing of Ophthalmic Drugs Growth	269.73%	-	-	-	-
Total	69.32M	18.75M	-	-	-
Total Growth	269.73%	-	-	-	-

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018
Hong Kong	803.00K	769.00K	-	-	-
Hong Kong Growth	4.42%	-	-	-	-
Mainland China	67.32M	12.38M	-	-	-
Mainland China Growth	443.71%	-	-	-	-
South Korea	1.19M	5.60M	-	-	-
South Korea Growth	-78.68%	-	-	-	-
Others	10.00K	-	-	-	-
Total	69.32M	18.75M	-	-	-
Total Growth	269.73%	-	-	-	-

Source: S&P Global Market Intelligence.